These findings indicate that Ang II promotes mitochondrial fragmentation and concurrent apoptosis in podocytes via the Sirt6‐ROCK1‐Drp1 pathway, which may offer a new therapeutic strategy for downstream overactivation of the RAAS in CKD. This evidence concerns the gene SIRT6 and chronic kidney disease.